We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDER Reports ‘Strong Year’ for Novel Drug Approvals
CDER Reports ‘Strong Year’ for Novel Drug Approvals
CDER Director Janet Woodcock flagged 2019 as a strong year for novel drug approvals, although the total dipped to 48 from the ten-year record of 59 for 2018.